Skip to Main Content Skip to Site Map Skip to Accessibility Statement

Trials in Analysis & Reporting

AcronymProtocol TitleStatus
ACEStudy of Technologies for the Diagnosis of Angle Closure glaucoma (ACE)Analysis and Reporting
A-STOPAntifungal stewardship opportunities with rapid tests for fungal infection in critically ill patients.Analysis and Reporting
CLEARA 2x2 factorial randomised open label trial to determine the clinical and cost- effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in bronchiectasisAnalysis and Reporting
EASI-SWITCHEarly switch to oral antibiotic therapy in patients with low risk neutropenic sepsis.Analysis and Reporting
EASYA multi-centre randomised, non-inferiority trial comparing parenteral antibiotics with oral antibiotics for the management of suspected urinary tract infections in well appearing young febrile infants.Analysis and Reporting
FROGA mixed methods feasibility perspectives study and pragmatic multi centred randomised controlled feasibility trial: Determining the feasibility of randomising children and young people to invasive or non-invasive urine sampling techniques (FROG)Analysis and Reporting
MARCHMucoactives in Acute Respiratory failure: Carbocisteine and Hypertonic saline.Analysis and Reporting
PHINDClinical Evaluation of a Point of Care (POC) assay to identify PHenotypes IN the Acute Respiratory Distress SyndromeAnalysis and Reporting
PREVENTION HARP-2Prevention Of Post-operative Complications By Using HMG-CoA
Reductase Inhibitor In Patients Undergoing Oesophagectomy – A
multicentre, randomised, double blind, placebo controlled trial
Analysis and Reporting
RESTProtective ventilation with veno-venous lung assist in respiratory failureAnalysis and Reporting
TEST-ITPoint Of Care Testing For Sepsis: A Diagnostic Accuracy StudyAnalysis and Reporting